Role Of Serum Soluble Transferrin Receptors (STFR) To Differentiate Iron Deficiency Anaemia And Anaemia Of Chronic Disease

Background:Iron deficiency is a common condition that is usually diagnosed using conventional laboratory tests of iron status, such as serum ferritin and transferrin saturation. However, both ferritin and transferrin proteins are markedly influenced by inflammation, behaving as acute-phase reactants and making it difficult to differentiate between iron-deficiency anemia (IDA) and anemia of chronic disease (ACD). Objectives: To evaluate the roleof serum soluble transferrin receptors (STFR) to differentiate iron deficiency anaemia and anaemia of chronic disease.Material And Methods:A cross-sectional study was conducted in the Department of Medicine, Victoria hospital and Bowring and Lady Curzonhospital, Bangalore Medical College and Research institute, Bangalore. A total of 150 blood samples were evaluated, i.e., 50 samples from iron deficiency anaemia group and 50 samples from patients with anaemia of chronic disorders & 50 samples from healthy normal individual.Result:In present study, samples are age matched with mean age of control 45.66±10.23, ACD 50.68±18.03, IDA 48.14±18.47. Hb, MCV, MCHC & MCH were decreased in both the groups. However, the decrease in Hb & MCV was much more in IDA as compared to ACD. Microcytosis was seen in 92% cases of IDA while it was observed in only 11% cases of ACD. Serum soluble transferrin receptor levels is <3 ?gm/ml in 90% of ACD group whereas >3 ?gm/ml in 78% of IDA Group.STFR/ log ferritin index was >1.5 in 80% of IDA. 90% of ACD and control subjects had STFR/log ferritin index <1.5. STFRlevels were significantly higher in IDA (7.7± 5.8) as compared to the ACD cases (1.6 ±0.89) (p<0.001). STFR/Log ferritin index is significantly higher in patients with Iron deficiency anemia (9.34±10.25) as compared to ACD (0.76±0.52) (p<0.001).Conclusion:The STFRlevels along with the STFR/Log ferritin index indices is very useful in differentiating pure IDA, ACD and ACD with coexisting iron deficiency, thus pr oviding anon invasive alternative to bone marrow iron.

Study of clinical and hematological profile of anemia in hospitalized geriatric patients

Background: Anemia is an important but underdiagnosed cause of morbidity in elderly. The clinical and hematological profile of anemia is different in different geographical area.Methods: It was a retrospective study. Case files of 50 geriatric patients admitted in Basaveshwara Medical College and Research Institute, Chitradurga with anemia, were selected for the above study. Male patients with Hb <13 g/dl and female patients with Hb <12 g/dl were considered in the study.Cases were analyzed to find out clinical and hematological profile of anemia.Results: The commonest clinical presentation was easy fatigability (70%), followed by dyspnea (50%). The commonest cause of anemia was iron deficiency (36%) followed by Vitamin B 12 and folate deficiency (24%), anemia of chronic disease(12%).Conclusions: Failure to evaluate anemia in elderly lead to delayed diagnosis of potentially treatable conditions. Nonspecific symptoms like fatigue and weakness should not be ignored, presuming that they are part of “normal ageing”. An effort should always be made to reach etiological diagnosis before instituting treatment. Role of NSAIDs as a risk factor in anemia should not be overlooked.

Diagnostic value and clinical significance of serum hepcidin level in iron deficiency anemia / 国际检验医学杂志

Objective To observe and explore the differentiation value of serum hepcidin level in iron defi-ciency anemia(IDA) and anemia of chronic disease(ACD) .Methods 40 cases of IDA in the hospital from Oc-tober 2015 to February 2017 and 40 cases of ACD were selected as the ACD group and in the same period 50 healthy people undergoing physical examination served as the control group .The ELISA method was adopted to detect serum hepcidin level in each group .The levels of serum iron and total iron binding capacity (TIBC) were detected by using the ferrous benzoxazines colorimetric method .Then the serum hepcidin levels were performed the contrastive analysis and statistical processing .Results The serum hepcidin level in the IDA group was lower than that in the control group ,the difference was statistically significant (P<0 .05) ,and ser-um hepcidin level in the ACD group was higher than that in control group ,the difference was statistically sig-nificant (P<0 .05) .The areas of under the receiver operating characteristic (ROC) curve for hepcidin ,serum iron ,TIBC in the differentiation diagnosis of ACD and IDA were 0 .98 ,0 .67 and 0 .86 respectively .Conclusion Serum hepcidin level is a simple and easy method for the differentiation diagnosis of IDA and ACD ,and its accuracy is superior to that of serum iron and TIBC levels .

Effect of Tongmai Yangxin Pill on the Serum Hepcidin Level of Patients with Coronary Atherosclerotic Heart Disease and Anemia of Chronic Disease / 现代生物医学进展

Objective:To investigate the effect of Tongrnai Yangxin Pill on the serum hepcidin level of patients with Coronary Atherosclerotic Heart Disease and Anemia of Chronic Disease.Methods:Seventy patients with Coronary Atherosclerotic Heart Disease and Anemia of Chronic Disease whose age were above 40 years old were enrolled as the research group and divided into the medication group (group Ⅱ) (n=35) and the nonmedication group (group Ⅲ)(n=35),while 40 CAD patients were enrolled as the normal control group (group Ⅰ).Before and after medication,the Hepc,Hb,etc levels were compared between two groups.Results:Before medication,the levels of Hepc in the two research subgroup were significantly higher than that of the control group (P＜0.05).At 8 weeks after treatment,the Hepc level of group Ⅱ was significantly declined,and the level of Hb was increased than those before treatment (P ＜0.05);the Hepc levels of group Ⅰ and group Ⅲ showed no significant difference (P＞0.05),the Hepc levels of group Ⅱ and group Ⅲ were obviously higher than that of the control group (P ＜0.05),the Hepc levels of group Ⅲ was obviously higher than that of the group Ⅱ(P＜0.05),the Hb level of group Ⅲ was obviously lower than those of group Ⅰ and group Ⅱ (P＜0.05).Conclusion:Tongmai Yangxin Pill could reduce the level of Hepc and enhance the Hb levels of patients with Coronary Atherosclerotic Heart Disease and Anemia of Chronic Disease.It was useful to the patients with Coronary Atherosclerotic Heart Disease and Anemia of Chronic Disease,especially patients with mild anemia.

Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia

BACKGROUND: Anemia of chronic disease (ACD) and iron deficiency anemia (IDA) are the two most prevalent forms of anemia having interrelated characteristics. Hepcidin, a newly introduced biomarker for assessment of iron status, is a homeostatic regulator of iron metabolism. We investigated the role of hepcidin and other conventional iron parameters to assess iron status among children with ACD and IDA. We also identified children with ACD who developed iron deficiency (ID). METHODS: The study was undertaken in anemic children with 30 cases each of ACD and IDA along with 30 age and sex-matched controls. The ACD cases were subdivided into pure ACD and ACD with coexistent ID. All cases were subjected to following tests: complete blood count with peripheral smear, serum C-reactive protein, serum interleukin-6, iron studies, serum soluble transferrin receptor (sTfR), and serum hepcidin. RESULTS: The mean serum hepcidin concentration was significantly increased in pure ACD patients (143.85±42.76 ng/mL) as compared to those in IDA patients (6.01±2.83 ng/mL, P < 0.001) and controls (24.96±9.09 ng/mL, P <0.001). Also, compared to pure ACD patients [normal sTfR levels (<3 µg/mL)], the serum hepcidin concentration was reduced significantly in ACD patients with ID [high sTfR levels (≥3 µg/mL)] with a mean of 10.0±2.97 ng/mL. CONCLUSION: Hepcidin measurement can provide a useful tool for differentiating ACD from IDA and also help to identify an iron deficiency in ACD patients. This might aid in the appropriate selection of therapy for these patients.

Diagnostic value of soluble transferrin receptor detection in non-adult ion deficiency anemia / 国际检验医学杂志

Objective To investigate the diagnostic value of the soluble transferrin receptor (sTfR)in non-adult iron deficiency anemia (IDA)and its differential diagnostic value between IDA and anemia of chronic disease(ACD).Methods 26 cases in the IDA group involved 12 males and 14 females,aged 1 month to 15.5 years;33 cases in the ACD group involved 17 males and 16 females, aged 2 months to 14.0 years;30 cases in the normal control group involved 15 males and 15 females,aged 1 month to 15.5 years. Serum sTfR and ferritin (SF)were detected by the immunonehelomitery,serum iron (SI)was detected by Ferrous Oxazine colori-metric method.Results The gender and age had no statistically significant difference among 3 groups;the SI mean value in the ACD group located between the IDA group′s and the normal control group′s;the SF mean value of the IDA group was significantly lower than that of ACD group (P <0.001)and that of control group (P <0.001),while the sTfR mean value of IDA group was significantly higher than that of the ACD group (P <0.001)and that of the normal control group (P <0.001).The best cutoff of sTfR for the differential diagnosis between IDA and ACD was 3.56 mg/L,its sensitivity,specificity,negative predictive value,posi-tive predictive value and accuracy were 95.12%,93.92%,94.11%,97.53% and 95.50% respectively.Conclusion sTfR has higher sensitivity and specificity for IDA and is conducive to diagnose IDA and differentially diagnose ACD.

Reticulocyte Indices for the Differential Diagnosis of Anemia of Chronic Disease and Iron Deficiency Anemia in Adult Women with Microcytic Hypochromic Anemia

BACKGROUND: Iron deficiency anemia (IDA) is the most common anemia followed by anemia of chronic disease (ACD). Reticulocyte indices have been shown to be helpful indicators for detecting IDA. We investigated whether RBC and reticulocyte indices can be used to differentiate ACD from IDA. METHODS: A total of 85 women showing microcytic hypochromic anemia (38 IDA and 47 ACD cases) were enrolled. IDA was defined as those with ferritin level of 450 microg/dL. ACD was defined as ferritin level of > or =6 microg/dL, TIBC of or =24.6 pg could be used to differentiate ACD from IDA with 85.1% sensitivity and 81.6% specificity. CONCLUSIONS: The reticulocyte indices, especially CHr, are useful for the differential diagnosis of microcytic hypochromic anemias, ACD and IDA.

Impacto da inflamação na regulação do ferro e deficiência funcional de ferro: [revisão] / Importance of inflammation on iron homeostasis and functional iron deficiency: [review]

Deficiência funcional de ferro (Fe) pode ser definida como o desbalanço entre a quantidade necessária de Fe para a síntese de hemoglobina e o seu suprimento. Ela ocorre na ausência de estoque de Fe, característica da anemia ferropênica (AF), e na presença de bloqueio da homeostasia do Fe, como na anemia da inflamação (AI). Na AI, citocinas e células do sistema retículo-endotelial induzem alterações que interferem em diferentes vias da eritropoese levando à anemia. O bloqueio na mobilização do Fe de estoque pela hepcidina, embora não único, é o mecanismo etiológico mais evidente da AI. A hepcidina, regulador negativo da entrada de Fe no plasma, atua ligando-se à ferroportina, induzindo sua internalização e degradação. Embora a diferenciação entre AF e AI seja relativamente tranquila, pacientes com AI podem cursar com deficiência de Fe associada. O diagnóstico diferencial entre AI e AI com deficiência de Fe tem evidente importância clínica, e novas técnicas laboratoriais têm sido sugeridas para auxiliar neste diagnóstico.

Functional iron deficiency can be defined as an imbalance between the iron needs of the erythroid marrow and iron supply. Iron deficiency occurs in the absence of iron deposits, as in the case of iron deficiency anemia (IDA), or when there is an impaired iron mobilization, such as in anemia of inflammation (AI). Cytokines and cells of the reticuloendothelial system can induce changes in several pathways, interfering in erythropoiesis and causing anemia. The retention of iron within cells of the reticuloendothelial system is due to hepcidin. Although this is not the only mechanism evolved in AI, it is the most important. Hepcidin is a negative regulator of iron entry into the plasma. Hepcidin binds to ferroportin, inducing its internalization and degradation. Differentiation between IDA and AI is relatively easy, but patients with AI can have the association of true iron deficiency. The differential diagnosis of AI and AI with iron deficiency is clinically important and new laboratorial markers can be used to help this differentiation.

Evaluation of serum transferrin receptor and sTfR ferritin indices in diagnosing and differentiating iron deficiency anemia from anemia of chronic disease.

Objective. The present study was conducted to assess the utility of serum transferrin receptor (sTfR) and sTfR ferritin indices to differentiate ACD from IDA and also to diagnose coexisting IDA and ACD. Methods. The study group comprised of 30 IDA patients, 30 cases of ACD and 30 age and sex matched controls. Complete hemogram with peripheral smear examination, markers of ACD, iron profile including serum ferritin and serum transferrin receptor levels were done in all patients and controls. Serum TfR and ferritin indices were calculated. Results. sTfR levels were significantly higher in the IDA group compared to ACD group (p<0.001). ACD group was further subdivided into two groups on the basis of sTfR levels (B1<3 μg/ml and B2 ≥ μg/ml), suggesting coexisting IDA in group B2. sTfR/log ferritin index was > 1.5 in all cases of IDA and ACD with coexisting IDA while all pure ACD cases and control subjects had sTfR/log ferritin index < 1.5. All case in IDA group had log sTfR/serum ferritin index > 2.55 and all patients with ACD with or without associated iron deficiency had log sTfR/serum ferritin ratio < 2.55. Conclusion. The sTfR levels along with the above mentioned indices can be very useful in differentiating pure IDA, ACD and ACD with coexisting iron deficiency, thus providing a noninvasive alternative to bone marrow iron.

Metabolismo do ferro: uma revisão sobre os principais mecanismos envolvidos em sua homeostase: [revisão] / Iron metabolism: an overview on the main mechanisms involved in its homeostasis: [revision]

Um perfeito sincronismo entre absorção, utilização e estoque de ferro é essencial para a manutenção do equilíbrio desse metal no organismo. Alterações nesses processos podem levar tanto à deficiência como ao seu acúmulo de ferro, duas situações com repercussões clínicas e laboratoriais importantes para o paciente. Essa revisão aborda os diversos aspectos relacionados com a cinética do ferro, descrevendo as proteínas e mediadores nela envolvidos. Apresenta, ainda, como é feita a regulação intracelular e sistêmica do ferro que visa a manutenção de uma quantidade ótima de ferro para o metabolismo das células e, em especial, para uma perfeita hematopoiese.É discutido também o importante papel da hepcidina, como regulador da homeostase sistêmica. Será a apresenta da a relação entre a hepcidina e a resposta de fase aguda, e como as alterações na expressão da hepcidina podem contribuir com a fisiopatogênese da anemia de doença crônica.

The perfect synchronism of intestinal absorption, use and storage of iron is critical for maintaining a balance in the organism. Disorders in these processes may lead either to iron deficiency or to iron overload, both of which have important clinical and laboratorial consequences for the patient. This review describes aspects related to iron metabolism and the participation of several proteins and mediators in these mechanisms. Moreover, intracellular and systemic regulation is responsible for providing the optimal iron concentration for cellular metabolism and, in particular, for adequate hematopoiesis. The relationship between hepcidin and acute phase response is presented and how changes in hepcidin expression may be related to the physiopathogenesis of anemia of chronic disease.

The diagnostic value of sTFR and its compound parameters in the differential diagnosis of iron deficiency anemia and anemia of chronic diseases / 医学研究生学报

Objectives: To clarify the diagnostic value of sTFR and its compound parameters sTFR/SF, sTFR/logSF in the differential diagnosis of IDA, ACD and CDID. Methods: Forty nine anemia patients were classified into IDA, ACD and CDID by clinical presentations and the laboratory results. The serum concentration of sTFR was detected by ELISA. The difference of sTFR, sTFR/SF, sTFR/logSF and routine parameters in the three groups and the correlation among sTFR and routine parameters were analyzed. Using ROC curve, the diagnostic value of these parameters in the differential diagnosis of the three diseases were compared. Results: The serum concentration of sTFR in the IDA, ACD and CDID were (50.8?8.2)nmol/L, (33.5?6.9)nmol/L and (22.7?9.9)nmol/L,respectively. The differences among three groups were significant( P

The diagnosis and treatment of anemia of chronic disease and renal anemia / 中国实用内科杂志

Anemia secondary to non-hematological and non-malignant diseases remains one of the clinical problems to be fully resolved,because of the complexity in pathogenesis and treatment.This paper only briefly reviews the clinical and hematologic findings,diagnosis and treatment for anemia of chronic disease and renal anemia.

Diagnostic availability of the soluble transferrin receptor in iron deficiency anemia and anemia of chronic disease / 대한임상병리학회지

BACKGROUND: In diagnoses of iron deficiency anemia(IDA) and anemia of chronic disease(ACD), bone marrow examinations, the gold standard, are too invasive. Iron parameters such as serum ferritin, iron, and total iron binding capacity(TIBC), may be altered by perturbations as varied as infection, inflammation, and malignancy. Clinically, IDA may be the initial manifestation of an occult carcinoma of the gastrointestinal tract, thus noninvasive methods with high sensitivity are now required in detecting tissue iron deficiency. In this study, we investigated the diagnostic availability of the soluble transferrin receptor(sTfR) in differential diagnosis of IDA and ACD. SUBJECTS AND METHODS: Thirty eight patients with uncomplicated IDA(ferritin or =60.0 microgram/L), 7 patients with combined anemia(IDA+ACD, 12.0 microgram/L< OR = ferritin <60.0 microgram/L), and 20 normal controls were included in the study. The blood levels of sTfR, hemoglobin(Hb), RBC indices, serum ferritin, serum iron, and TIBC were measured and the transferrin saturation was calculated. The sTfR levels were compared with each other group. The correlations between iron parameters and the sTfR levels were investigated in each group. RESULTS: The sTfR receptor levels were significantly higher in uncomplicated IDA patients(56.2+/-19.8 nmol/L) than in normal controls(17.9+/-3.9 nmol/L) and uncomplicated ACD patients(15.3+/-7.5 nmol/L). No difference of the sTfR concentrations was observed between ACD patients and normal controls. In combined group, four of the 7 cases showed higher sTfR values than that of normal controls. Good inverse correlation was observed between Hb and sTfR levels in uncomplicated IDA group. There were no correlations between iron parameters and sTfR levels in the other groups. CONCLUSION: Because the sTfR level was not elevated in ACD and was significantly higher in IDA, blood determination of the sTfR levels may be a useful method in differential diagnosis of IDA and ACD. The sTfR is the most useful marker expressing the functional iron deficiency without being affected by chronic diseases. Because the sTfR levels were inversely correlated with Hb in IDA patients, the combined use of two parameters, ferritin and sTfR which are the indices of storage iron and functional iron respectively, may allow accurate definition of the entire range of body iron status.